VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,769 | -84.7% | 14,530 | -76.7% | 0.00% | – |
| Q2 2023 | $410,419 | +16.7% | 62,279 | +20.2% | 0.00% | – |
| Q1 2023 | $351,831 | +2298.5% | 51,816 | +2510.4% | 0.00% | – |
| Q4 2022 | $14,669 | -68.1% | 1,985 | -56.3% | 0.00% | – |
| Q3 2022 | $46,000 | -14.8% | 4,544 | -9.2% | 0.00% | – |
| Q2 2022 | $54,000 | -94.4% | 5,003 | -94.2% | 0.00% | – |
| Q1 2022 | $971,000 | -38.7% | 85,908 | -14.9% | 0.00% | – |
| Q4 2021 | $1,583,000 | -70.3% | 100,903 | -67.5% | 0.00% | -100.0% |
| Q3 2021 | $5,329,000 | -40.5% | 310,933 | -25.3% | 0.00% | -50.0% |
| Q2 2021 | $8,953,000 | +306.8% | 416,200 | +184.0% | 0.00% | – |
| Q1 2021 | $2,201,000 | +19.0% | 146,568 | +4.2% | 0.00% | – |
| Q4 2020 | $1,849,000 | +43.8% | 140,716 | +5.7% | 0.00% | – |
| Q3 2020 | $1,286,000 | -21.0% | 133,188 | -6.4% | 0.00% | – |
| Q2 2020 | $1,627,000 | -20.1% | 142,250 | -27.6% | 0.00% | -100.0% |
| Q1 2020 | $2,036,000 | -63.5% | 196,489 | -42.2% | 0.00% | -50.0% |
| Q4 2019 | $5,577,000 | +265.0% | 339,841 | +195.4% | 0.00% | – |
| Q3 2019 | $1,528,000 | +1.9% | 115,054 | +8.1% | 0.00% | – |
| Q2 2019 | $1,499,000 | -27.2% | 106,396 | -4.8% | 0.00% | -100.0% |
| Q1 2019 | $2,058,000 | -91.1% | 111,773 | -87.3% | 0.00% | -87.5% |
| Q4 2018 | $23,021,000 | +53.8% | 881,031 | +35.1% | 0.01% | +100.0% |
| Q3 2018 | $14,971,000 | +498.8% | 652,305 | +396.9% | 0.00% | +300.0% |
| Q2 2018 | $2,500,000 | +40.5% | 131,265 | +24.3% | 0.00% | 0.0% |
| Q1 2018 | $1,779,000 | -32.8% | 105,567 | -39.4% | 0.00% | 0.0% |
| Q4 2017 | $2,649,000 | -2.4% | 174,222 | +14.9% | 0.00% | 0.0% |
| Q3 2017 | $2,715,000 | +133.0% | 151,693 | +112.2% | 0.00% | – |
| Q2 2017 | $1,165,000 | -29.7% | 71,484 | -39.6% | 0.00% | -100.0% |
| Q1 2017 | $1,658,000 | -13.1% | 118,364 | -1.0% | 0.00% | 0.0% |
| Q4 2016 | $1,907,000 | +127.6% | 119,571 | +137.3% | 0.00% | – |
| Q3 2016 | $838,000 | +52.1% | 50,392 | +2.3% | 0.00% | – |
| Q2 2016 | $551,000 | +308.1% | 49,242 | +203.9% | 0.00% | – |
| Q1 2016 | $135,000 | +3.1% | 16,205 | +14.9% | 0.00% | – |
| Q4 2015 | $131,000 | -57.6% | 14,104 | -48.5% | 0.00% | – |
| Q3 2015 | $309,000 | -27.0% | 27,412 | -17.7% | 0.00% | – |
| Q2 2015 | $423,000 | -53.1% | 33,318 | -65.6% | 0.00% | – |
| Q1 2015 | $902,000 | +257.9% | 96,962 | +452.8% | 0.00% | – |
| Q4 2014 | $252,000 | -35.9% | 17,540 | -53.7% | 0.00% | – |
| Q3 2014 | $393,000 | -11.9% | 37,916 | +37.6% | 0.00% | – |
| Q2 2014 | $446,000 | -13.6% | 27,560 | -13.2% | 0.00% | – |
| Q1 2014 | $516,000 | -93.7% | 31,743 | -95.2% | 0.00% | -100.0% |
| Q4 2013 | $8,216,000 | -40.1% | 662,059 | -47.2% | 0.00% | -42.9% |
| Q3 2013 | $13,724,000 | +343000.0% | 1,253,400 | +226965.2% | 0.01% | – |
| Q2 2013 | $4,000 | – | 552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |